LIC MF Healthcare Fund Direct Growth

Equity

Sector - Healthcare

NAV as on 28-03-2025

₹ 30.75

▲0.4%

Inception Returns

20.3%

/yr

Historical NAV & Returns

Absolute

▲

▼

135 people have invested ₹ 3.7L in LIC MF Healthcare Fund Direct Growth in the last three months

About LIC MF Healthcare Fund Direct Growth

LIC MF Healthcare Fund Direct Growth is an equity fund. This fund was started on 28 February, 2019. The fund is managed by Karan Doshi. The fund could potentially beat inflation in the long-run.

Key Parameters

LIC MF Healthcare Fund Direct Growth has ₹77 Cr worth of assets under management (AUM) as on Feb 2025 and is less than category average.
The fund has an expense ratio 1.2.

Returns

LIC MF Healthcare Fund Direct Growth has given a CAGR return of 20.30% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 20.73%, 17.76% and 25.65% respectively.

Holdings

LIC MF Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Piramal Pharma Ltd, Torrent Pharmaceuticals Ltd, Artemis Medicare Services Ltd Ordinary Shares, Abbott India Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of LIC MF Healthcare Fund Direct Growth

The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 200.00. LIC MF Healthcare Fund Direct Growth has no lock in period.

LIC MF Healthcare Fund Direct Growth Overview

Expense ratio	1.22%
Benchmark	S&P BSE Healthcare PR
AUM	₹77 Cr
Inception Date	28 February, 2019
Min Lumpsum/SIP	₹5000/₹200
Exit Load	1.0%
Lock In	No Lock-in
TurnOver	414.8%
STCG	Selling mutual fund before 1 year, returns taxed at 20%.
LTCG	After 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk	Very High Risk

INDmoney Rank for LIC MF Healthcare Fund Direct Growth

IND ranking is not available for this fund.

Beats FD returns for both 3Y & 5Y duration

5Y returns in the bottom 25% of the category

3Y returns in the bottom 25% of the category

Trailing Returns

as on (28-Mar-25)

Period	LIC MF Healthcare Fund Direct Growth	Nifty 500	sector - healthcare
1M	8.8%	7.3%	7.5%
3M	-5.9%	-4.6%	-7.6%
6M	-4.3%	-12%	-7.9%
1Y	20.7%	5.4%	16.4%
3Y	17.8%	12.7%	18.6%
5Y	25.6%	25.9%	28.1%

Fund Distribution

as on (28-Feb-25)

Equity 97.6%
Debt & Cash 2.4%

Small cap

33.8%

Mid cap

28.9%

Large cap

26.6%

Sector Allocation

Feb'25

Jan'25

Dec'24

Health

93.2%

Basic Materials

6.8%

All changes are between Dec'24 and Feb'25

	Dec'24
Fund Returns	0.84%
Nifty 500	-2.02%

Parameters	Feb'25	Jan'25	Dec'24
AUM	₹ 76.7 Cr	₹ 83.9 Cr	₹ 84.1 Cr

AUM of the fund stands at 76.7 Cr as of Feb'25
AUM decreased by 7.1 Cr between Feb'25 and Jan'25

Top Stocks bought last month

Abbott India Ltd's allocation increased from 3.73% to 4.73%

Suven Pharmaceuticals Ltd's allocation increased from 3.3% to 4.16%

Vinati Organics Ltd's allocation increased from 2.08% to 2.75%

Top Stocks sold last month

Sun Pharmaceuticals Industries Ltd's allocation decreased from 9.94 % to 9.93 %

Piramal Pharma Ltd's allocation decreased from 6.85 % to 5.37 %

Torrent Pharmaceuticals Ltd's allocation decreased from 5.28 % to 5.2 %

Large Cap allocation has gone down from 33.6% to 26.6%

Small Cap allocation has gone up from 33.5% to 33.8%

Mid Cap allocation has gone up from 23.5% to 28.9%

Cash allocation has gone down from 2.9% to 2.4%

Top 2 Sectors in February were Health, Basic Materials

Feb'25

Health

93%

Basic Materials

Jan'25

Health

93%

Basic Materials

Equity

Holdings	Weight%	1M Change
Sun Pharmaceuticals Industries Ltd	9.93%	0%
Piramal Pharma Ltd	5.37%	-12%
Torrent Pharmaceuticals Ltd	5.2%	0%
Artemis Medicare Services Ltd Ordinary Shares	5.15%	0%
Abbott India Ltd	4.73%	0%

See all

Returns %
Fund Ratios
Overview

Funds	1Y Returns	3Y Returns	5Y Returns	Since Inception
LIC MF Healthcare Fund Direct Growth	20.73%	17.76%	25.65%	20.3%
UTI Healthcare Fund-Growth Option- Direct	21.26%	21%	29.84%	16.27%
SBI Healthcare Opportunities Fund Direct Growth	21.25%	24.58%	31.9%	18.29%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth	20.88%	23.86%	32.79%	22.44%

See all

Gainers
Losers

Top Growth Drivers	1M Return
Suven Pharmaceuticals Ltd	1%

Fund	Feb'25	Jan'25	Dec'24
No of Holdings	28	27	26
Top 5 Company Concentration	30.4%	32.8%	33.6%
Company having highest exposure	Sun Pharmaceuticals Industries Ltd (9.9%)	Sun Pharmaceuticals Industries Ltd (9.9%)	Sun Pharmaceuticals Industries Ltd (10.5%)
No of Sectors	2	2	2
Top 5 Sectors Concentration	100%	100%	100%
Sector having highest exposure	Health (93.2%)	Health (93.4%)	Health (96.1%)

We are taking more time than usual

Karan Doshi

Fund Manager of LIC MF Healthcare Fund Direct Growth, since 31 July 2023

Top funds managed

Scheme	Annualised Returns(3Y)	Category Returns(3Y)
LIC MF Dividend Yield Fund Direct Growth	19.92%	17.17%
LIC MF Aggressive Hybrid Fund Direct Plan Growth Option	12.22%	13.16%
LIC MF Midcap Fund Direct Growth	19.18%	19.17%

Fund House

LIC Mutual Fund Asset Management Limited

Total Schemes

See all LIC schemes

Total AUM

₹30.83K Cr

as on 28-Feb-2025

Address

LIC Mutual Fund Asset Management Limited,4th Floor, Industrial Assurance Building,,Opp. Churchgate Station,

Phone

+91022-66016000

Website

licmfamc@licmutual.com

Mutual Fund Insights

In the last 1 year, HDFC Pharma and Healthcare Fund Direct Growth has given 31.15% return, outperforming this fund by 10.42%.

Over the last 6 months, this fund has experienced a 7.1% growth in AUM moving from 71.64 Cr to 76.74 Cr.

In the last 5 years, ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth has given 32.79% return, outperforming this fund by 7.15% per annum.

In the last 3 years, SBI Healthcare Opportunities Fund Direct Growth has given 24.58% return, outperforming this fund by 6.82% per annum.

This fund has one of the lowest expense ratio in the category (sector - healthcare). Its expense ratio is 1.22% which is lower than the category average expense ratio of 1.41%.

LIC MF Healthcare Fund Direct Growth Highlights

Very High Risk

Investors understand that their principal will be at Very High Risk

About the fund

This fund has delivered an average annual returns of 20.3% since inception which is more than its category average return of 17.1%

Fund Allocations

This fund has an allocation of 97.63% in Equity, 0% in Debt and 2.37% in Cash related instruments

AUM size ₹77 Cr

This fund has AUM of ₹77 Cr which is less than its category average of ₹ 1725 Cr

Expense Ratio 1.22%

This fund has an expense ratio of 1.22% which is less than its category average expense ratio of 1.45%

Frequently Asked Questions for LIC MF Healthcare Fund Direct Growth

The current NAV of LIC MF Healthcare Fund Direct Growth is ₹30.75 as on 28-Mar-2025.

Existing (Absolute + CAGR) as on 28-Mar-2025.

LIC MF Healthcare Fund Direct Growth	Absolute Returns	CAGR Returns
1 Month Returns	8.82%	8.82%
6 Month Returns	-4.31%	-4.31%
1 Year Returns	20.73%	20.73%
3 Years Returns	63.3%	17.76%
5 Years Returns	213.13%	25.65%

With INDmoney, the process of investing is very simple and involves zero commission.

Click Buy on the fund name.
Input the amount you are looking to invest.
Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
Select your bank account and proceed with Payment.

1.22% as on March 2025

₹77 Cr as on March 2025

Sun Pharmaceuticals Industries Ltd(9.93%), Piramal Pharma Ltd(5.37%), Torrent Pharmaceuticals Ltd(5.2%), Artemis Medicare Services Ltd Ordinary Shares(5.15%), Abbott India Ltd(4.73%) as on March 2025

The alpha ratio for the LIC MF Healthcare Fund Direct Growth for various period is as follows:

Fund Name	Alpha 1 Year	Alpha 3 Years	Alpha 5 Years
LIC MF Healthcare Fund Direct Growth	2.48	-1.54	-1.5

As on March 2025

The alpha for LIC MF Healthcare Fund Direct Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.

The Beta ratio for the LIC MF Healthcare Fund Direct Growth for various period is as follows:

Fund Name	Beta 1 Year	Beta 3 Years	Beta 5 Years
LIC MF Healthcare Fund Direct Growth	0.92	0.92	0.92

As on March 2025

The Beta for LIC MF Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.

The sharpe ratio for the LIC MF Healthcare Fund Direct Growth for various period is as follows:

Fund Name	Sharpe Ratio 1 Year	Sharpe Ratio 3 Years	Sharpe Ratio 5 Years
LIC MF Healthcare Fund Direct Growth	0.34	0.61	0.8

As on March 2025

The sharpe ratio for LIC MF Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.

The standard deviation for the LIC MF Healthcare Fund Direct Growth for various period is as follows:

Fund Name	Standard Deviation 1 Year	Standard Deviation 3 Years	Standard Deviation 5 Years
LIC MF Healthcare Fund Direct Growth	18.01	15.99	19.29

As on March 2025

Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.

Sortino ratio is 1.01 as on March 2025. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.

Karan Doshi is the fund manager of LIC MF Healthcare Fund Direct Growth

The Exit load of LIC MF Healthcare Fund Direct Growth is 1%

LIC MF Healthcare Fund Direct Growth

Historical NAV & Returns

About LIC MF Healthcare Fund Direct Growth

Key Parameters

Returns

Holdings

Taxation

Investment objective of LIC MF Healthcare Fund Direct Growth

Minimum Investment and lockin period

LIC MF Healthcare Fund Direct Growth Overview

INDmoney Rank for LIC MF Healthcare Fund Direct Growth

Trailing Returns

Fund Distribution

Monthly Changes

Top Holdings

Peer Comparison

Gainers & Losers

Concentration Analysis

Fund Manager

AMC Details

Mutual Fund Insights

LIC MF Healthcare Fund Direct Growth Highlights

Very High Risk

About the fund

Fund Allocations

AUM size ₹77 Cr

Expense Ratio 1.22%

Frequently Asked Questions for LIC MF Healthcare Fund Direct Growth

What is the current NAV of LIC MF Healthcare Fund Direct Growth?

What are the average returns of LIC MF Healthcare Fund Direct Growth?

How do I invest in LIC MF Healthcare Fund Direct Growth?

What is the expense ratio of LIC MF Healthcare Fund Direct Growth?

What is net assets under management (AUM) of LIC MF Healthcare Fund Direct Growth?

What are the top 5 holdings of LIC MF Healthcare Fund Direct Growth?

What is the alpha of LIC MF Healthcare Fund Direct Growth?

What is the beta of LIC MF Healthcare Fund Direct Growth??

What is the sharpe ratio of LIC MF Healthcare Fund Direct Growth?

What is the standard deviation of LIC MF Healthcare Fund Direct Growth?

What is the Sortino ratio of LIC MF Healthcare Fund Direct Growth?

Who is the manager of LIC MF Healthcare Fund Direct Growth?

What is the exit load of LIC MF Healthcare Fund Direct Growth?